By Jeff Montgomery ( February 20, 2019, 7:55 PM EST) -- Pointing to concerns over generic-drug maker Akorn Inc.'s financial outlook, Fresenius Kabi AG told the Chancery Court late Tuesday it wants an expedited ruling on damages claims arising from the two companies' scuttled $4.3 billion merger....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.